60134
Chlorure de potassium solution
conductance standard A acc. to ISO 7888, 0.1 M KCl
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule linéaire :
KCl
Numéro CAS:
Poids moléculaire :
74.55
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1711999
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderQuality Level
concentration
0.1 M KCl
conductivity
12.90 mS/cm at 25 °C
application(s)
cleaning products
cosmetics
environmental
flavors and fragrances
food and beverages
personal care
format
single component solution
SMILES string
[Cl-].[K+]
InChI
1S/ClH.K/h1H;/q;+1/p-1
InChI key
WCUXLLCKKVVCTQ-UHFFFAOYSA-M
Application
Analyticalstandard for calibration and verification of conductivity measurementequipment.
Still not finding the right product?
Explore all of our products under Chlorure de potassium solution
Classe de stockage
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Vapor pressure and specific electrical conductivity in the H2O-LiH2PO4-LiPO3 system?a novel electrolyte for water electrolysis at elevated temperature
Berg RW, et al.
Ionics, 27(2), 703-719 (2021)
Mikaela M Ceder et al.
Frontiers in cell and developmental biology, 8, 580291-580291 (2020-11-10)
The number of transporter proteins that are not fully characterized is immense. Here, we used Drosophila melanogaster and human cell lines to perform a first in-depth characterization of CG4928, an ortholog to the human UNC93A, of which little is known.
Masatoshi Takagaki et al.
Experimental neurology, 252, 12-17 (2013-11-20)
Sedatives in the neurointensive care unit can strongly influence patients' risks of developing secondary brain damage. In particular, isoflurane, a volatile anesthetic, has been recently re-introduced to the neurointensive care unit, and first clinical studies suggest beneficial effects due to